Related references
Note: Only part of the references are listed.Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes
T. E. Kahkonen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth
Marilena Tauro et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Arko Dasgupta et al.
MOLECULAR ONCOLOGY (2017)
Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17
J. S. Frieling et al.
ONCOGENE (2017)
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis
Hai Li et al.
ONCOLOGY LETTERS (2017)
Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion
Ching-Fang Yu et al.
BRITISH JOURNAL OF CANCER (2017)
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the, bone marrow
Rachelle W. Johnson et al.
NATURE CELL BIOLOGY (2016)
Forcing throuch Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition
Spencer C. Wei et al.
TRENDS IN CELL BIOLOGY (2016)
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Kenji Yumoto et al.
SCIENTIFIC REPORTS (2016)
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Hai Wang et al.
CANCER CELL (2015)
The role of EMT and MET in cancer dissemination
Jacqueline Banyard et al.
CONNECTIVE TISSUE RESEARCH (2015)
Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases
Andreia L. Bates et al.
JOURNAL OF PATHOLOGY (2015)
High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma
Hongwei Guo et al.
ONCOTARGET (2015)
Tissue Stiffness Dictates Development, Homeostasis, and Disease Progression
Andrew M. Handorf et al.
ORGANOGENESIS (2015)
Evidence for the Involvement of MMP14 in MMP2 Processing and Recruitment in Exosomes of Corneal Fibroblasts
Kyu-Yeon Han et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
The Cooperation of CREB and NFAT Is Required for PTHrP-Induced RANKL Expression in Mouse Osteoblastic Cells
Hyun-Jung Park et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis
Yiping Chen et al.
PLOS ONE (2015)
Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma
F. Q. Yang et al.
ACTAS UROLOGICAS ESPANOLAS (2014)
New approaches to selectively target cancer-associated matrix metalloproteinase activity
Marilena Tauro et al.
CANCER AND METASTASIS REVIEWS (2014)
Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses
Emmanuelle Godefroy et al.
CELL REPORTS (2014)
Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells
Craig E. Barcus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
The perivascular niche regulates breast tumour dormancy
Cyrus M. Ghajar et al.
NATURE CELL BIOLOGY (2013)
PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells
Teppei Watanabe et al.
ARCHIVES OF ORAL BIOLOGY (2012)
The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model
Hui Liu et al.
BMC CANCER (2012)
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Hector Peinado et al.
NATURE MEDICINE (2012)
An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment
Sophie Thiolloy et al.
PLOS ONE (2012)
An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer
Manisha Shah et al.
PLOS ONE (2012)
Disentangling Structural Brain Alterations Associated With Violent Behavior From Those Associated With Substance Use Disorders
Boris Schiffer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis
Conor C. Lynch
BONE (2011)
Biochemical and molecular mechanisms of action of bisphosphonates
Michael J. Rogers et al.
BONE (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Host MMP-2 impacts tumor survival in the metastatic bone microenvironment through a TGFβ dependent mechanism
Sophie Thiolloy et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption
Maria Teresa Rubino et al.
CHEMMEDCHEM (2011)
The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
Hector Peinado et al.
SEMINARS IN CANCER BIOLOGY (2011)
Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation
Jessica McCready et al.
BMC CANCER (2010)
Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration
Aaron L. Sabbota et al.
CANCER RESEARCH (2010)
MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells
Chandramu Chetty et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: Role of cAMP-dependent protein kinase
Hiroshi Kaji et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
Marta Coscia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Multiplex N-terminome Analysis of MMP-2 and MMP-9 Substrate Degradomes by iTRAQ-TAILS Quantitative Proteomics
Anna Prudova et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
Navigating ECM Barriers at the Invasive Front: The Cancer Cell-Stroma Interface
R. Grant Rowe et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
A tense situation: forcing tumour progression
Darci T. Butcher et al.
NATURE REVIEWS CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
P. M. McGowan et al.
ANNALS OF ONCOLOGY (2008)
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
Fraser P. Coxon et al.
BONE (2008)
Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer.
Jian Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression
Li Qin et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2
Odete Mendes et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor
Conor C. Lynch et al.
CANCER RESEARCH (2007)
The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases
Benedicte Cauwe et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand
Atsuhiko Hikita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism
Keiichi Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Matrix metalloproteinase 2 activation of transforming growth factor-β1 (TGF-β1) and TGF-β1-type II receptor signaling within the aged arterial wall
Mingyi Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-κB ligand pathway
MS Bendre et al.
CANCER RESEARCH (2005)
Matrix metalloproteinase inhibitors as anticancer therapeutics
F Mannello et al.
CURRENT CANCER DRUG TARGETS (2005)
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
CC Lynch et al.
CANCER CELL (2005)
Latent transforming growth factor-β (TGF-β) binding proteins:: Orchestrators of TGF-β availability
DB Rifkin
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer
YK Lee et al.
JOURNAL OF GENE MEDICINE (2005)
Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
M Héroult et al.
ONCOGENE (2004)
Tumour invasion and matrix metalloproteinases
M Polette et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice
AM Tester et al.
CANCER RESEARCH (2004)
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases
T Hagemann et al.
CARCINOGENESIS (2004)
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice
D Stickens et al.
DEVELOPMENT (2004)
Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone
S Roelle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
A Talvensaari-Mattila et al.
BRITISH JOURNAL OF CANCER (2003)
Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis
T Ohshiba et al.
BRITISH JOURNAL OF CANCER (2003)
Mechanisms of osteolytic bone metastases in breast carcinoma
SM Käkönen et al.
CANCER (2003)
MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival
L Nakopoulou et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Matrix metalloproteinases in tumor - host cell communication
CC Lynch et al.
DIFFERENTIATION (2002)
Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165
G Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts -: A cellular mechanism for release of TGF-β from bone matrix
SL Dallas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Latent TGF-β binding protein-3 (LTBP-3) requires binding to TGF-β for secretion
Y Chen et al.
FEBS LETTERS (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Bone abnormalities in latent TGF-β binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability
B Dabovic et al.
JOURNAL OF CELL BIOLOGY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Timeline - Matrix metalloproteinases: a tail of a frog that became a prince
CE Brinckerhoff et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1
GA McQuibban et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Distinct antitumor properties of a type IV collagen domain derived from basement membrane
Y Maeshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Matrix metalloproteinases: Biologic activity and clinical implications
AR Nelson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
